Resultados de la búsqueda 661-670 of 1448 for plant-based reset
All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...
To assure that the derived cell lines and micro-cancer models have not been cross contaminated during development with other models in development, DNA ...
By comparing the gene expression of motor neurons derived from iPSC cells of phenotypically discordant Spinal Muscular Atrophy (SMA) sibling pairs and ...
(Z)-endoxifen belongs to a group of drugs called selective estrogen receptor modulators or "SERM", which help block estrogen from attaching to cancer cells.
Rochester, Minn. The purposes of this study are to analyze the ovarian function of female premenopausal melanoma survivors who have undergone immunotherapy, and ...
... based on RECIST 1.1 criteria and will be documented at each enrolling site with no central review planned. Ommaya Placement for Biomarker Collection.
The purpose of this study is to evaluate nurse-based care coordination compared to usual care on 30-day risk-adjusted readmission rates among high risk patients ...
... based on RECIST 1.1 criteria and will be documented at each enrolling site with no central review planned. Numeración de páginas Estudios clínicos. Anterior ...
The principal clinician, working with a multidisciplinary team, will develop a specific treatment plan for each patient, based upon the presenting condition ...
The purpose of this study is investigate if functions and composition of the gut microbiome are associated with the occurrence of chemotherapy-induced ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?